204 related articles for article (PubMed ID: 24844359)
1. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Leuk Lymphoma; 2015 Feb; 56(2):480-91. PubMed ID: 24844359
[TBL] [Abstract][Full Text] [Related]
2. NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.
Nagel S; Pommerenke C; Scherr M; Meyer C; Kaufmann M; Battmer K; MacLeod RA; Drexler HG
PLoS One; 2017; 12(2):e0171164. PubMed ID: 28151996
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic deregulation of NKL homeobox gene MSX1 in mantle cell lymphoma.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Leuk Lymphoma; 2014 Aug; 55(8):1893-903. PubMed ID: 24237447
[TBL] [Abstract][Full Text] [Related]
5. Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.
Nagel S; Meyer C; Kaufmann M; Zaborski M; MacLeod RAF; Drexler HG
PLoS One; 2018; 13(5):e0197194. PubMed ID: 29746601
[TBL] [Abstract][Full Text] [Related]
6. Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Przybylski GK; Grabarczyk P; Schneider B; Meyer C; Kaufmann M; Schmidt CA; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Jul; 52(7):1348-59. PubMed ID: 21425961
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia.
Nagel S; Pommerenke C; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2016 Jul; 7(29):45398-45413. PubMed ID: 27322685
[TBL] [Abstract][Full Text] [Related]
9. NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia.
Nagel S; Pommerenke C; Meyer C; Kaufmann M; MacLeod RAF; Drexler HG
Oncotarget; 2017 Sep; 8(40):66815-66832. PubMed ID: 28977998
[TBL] [Abstract][Full Text] [Related]
10. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
[TBL] [Abstract][Full Text] [Related]
11. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
12. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia.
Tan SH; Yam AW; Lawton LN; Wong RW; Young RA; Look AT; Sanda T
Leukemia; 2016 Apr; 30(4):959-62. PubMed ID: 26202930
[No Abstract] [Full Text] [Related]
13. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
[TBL] [Abstract][Full Text] [Related]
14. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
15. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
[TBL] [Abstract][Full Text] [Related]
16. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
[TBL] [Abstract][Full Text] [Related]
17. BMP signaling patterns the dorsal and intermediate neural tube via regulation of homeobox and helix-loop-helix transcription factors.
Timmer JR; Wang C; Niswander L
Development; 2002 May; 129(10):2459-72. PubMed ID: 11973277
[TBL] [Abstract][Full Text] [Related]
18. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
19. NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma.
Nagel S; MacLeod RAF; Pommerenke C; Meyer C; Kaufmann M; Drexler HG
Oncotarget; 2018 Dec; 9(101):37480-37496. PubMed ID: 30680064
[TBL] [Abstract][Full Text] [Related]
20. Homeobox protein MSX-1 inhibits expression of bone morphogenetic protein 2, bone morphogenetic protein 4, and lymphoid enhancer-binding factor 1 via Wnt/β-catenin signaling to prevent differentiation of dental mesenchymal cells during the late bell stage.
Feng XY; Wu XS; Wang JS; Zhang CM; Wang SL
Eur J Oral Sci; 2018 Feb; 126(1):1-12. PubMed ID: 29148101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
